Niagen Bioscience Announces $10 Million Share Repurchase Program

Core Viewpoint - Niagen Bioscience, Inc. has announced a share repurchase program authorized by its Board of Directors, allowing the company to repurchase up to $10 million of outstanding common stock over approximately 24 months [1] Company Summary - Niagen Bioscience, Inc. is recognized as a global authority on NAD+ (nicotinamide adenine dinucleotide) and focuses on the science of healthy aging [1] - The company expresses confidence in its investment potential, describing the share repurchase program as a compelling opportunity [1]